-
Joan S. Braveman, director of patient access and financial services at Tallahassee (FL) Memorial HealthCare, says that her department has put a "very liberal, but very fair, uninsured payment policy in place."
-
If some particularly dismal copay collection data came to your attention, chances are you'd want to scrutinize it carefully before presenting this to senior leaders.
-
Two major areas of concern for the switch to ICD-10 are medical necessity and preauthorizations, according to Susan Hoyle, CCS, coding manager at Mission Hospitals in Asheville, NC.
-
Offering large salary increases or promotions is probably not an option to improve retention, even for your most irreplaceable staff members. However, it's possible that staff might jump at the chance for a lateral move within the patient access department, according to Sherrie Woodmancy, service director for patient billing and financial services at University of Utah Health Care in Salt Lake City.
-
The secret to any process improvement in the ED is the relationship that your registration staff have with the clinical staff and management, according to Tina Nadrasik, patient access manager in the ED at Bronson Methodist Hospital in Kalamazoo, MI.
-
As self-pay patients continue to rise in number, you'll need effective strategies for screening these individuals for charity eligibility.
-
IRB professionals might not have gotten into the business of protecting human subjects because of their love for mathematics and statistics. But many now are finding that tracking data and analyzing numbers helps them do their job better.
-
When internal job mobility is stagnated, it can result in high staff turnover rates a problem no IRB wants to experience.
-
IRB offices routinely handle protocol submissions that are incomplete or flawed in other fundamental ways. These problems cause roadblocks that slow down the IRB approval process and frustrate investigators and IRB staff alike.
-
A recent analysis of clinical trials showed that researchers routinely ignored previously published and relevant clinical trials when conducting their own studies.
